Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$42.05 - $47.77 $5.2 Million - $5.91 Million
-123,697 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$40.23 - $47.74 $4.98 Million - $5.91 Million
123,697 New
123,697 $5.39 Million
Q4 2020

Feb 12, 2021

SELL
$34.07 - $39.94 $76.7 Million - $90 Million
-2,252,302 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$38.11 - $42.99 $20.1 Million - $22.7 Million
-528,431 Reduced 19.0%
2,252,302 $84.8 Million
Q2 2020

Aug 13, 2020

SELL
$37.87 - $43.58 $23.1 Million - $26.6 Million
-609,923 Reduced 17.99%
2,780,733 $113 Million
Q1 2020

May 13, 2020

SELL
$32.47 - $48.83 $17 Million - $25.6 Million
-523,786 Reduced 13.38%
3,390,656 $128 Million
Q4 2019

Feb 14, 2020

BUY
$42.0 - $48.25 $746,508 - $857,595
17,774 Added 0.46%
3,914,442 $184 Million
Q3 2019

Nov 14, 2019

SELL
$40.46 - $43.52 $1.47 Million - $1.58 Million
-36,333 Reduced 0.92%
3,896,668 $166 Million
Q2 2019

Aug 14, 2019

SELL
$39.4 - $42.7 $196,960 - $213,457
-4,999 Reduced 0.13%
3,933,001 $157 Million
Q1 2019

May 10, 2019

SELL
$38.57 - $42.69 $3.25 Million - $3.6 Million
-84,220 Reduced 2.09%
3,938,000 $165 Million
Q4 2018

Feb 13, 2019

BUY
$37.8 - $42.69 $80,325 - $90,716
2,125 Added 0.05%
4,022,220 $157 Million
Q3 2018

Nov 13, 2018

SELL
$39.75 - $42.69 $13.8 Million - $14.8 Million
-346,080 Reduced 7.93%
4,020,095 $161 Million
Q2 2018

Aug 10, 2018

BUY
$39.61 - $42.76 $2.93 Million - $3.16 Million
73,981 Added 1.72%
4,366,175 $176 Million
Q1 2018

May 09, 2018

SELL
$36.18 - $40.15 $26.8 Million - $29.7 Million
-740,665 Reduced 14.72%
4,292,194 $168 Million
Q4 2017

Feb 14, 2018

SELL
$35.34 - $41.9 $15.6 Million - $18.5 Million
-442,227 Reduced 8.08%
5,032,859 $0
Q3 2017

Nov 13, 2017

BUY
$39.44 - $41.55 $216 Million - $227 Million
5,475,086
5,475,086 $222 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.